• 1
    Boomsma MM, Bijl M, Stegeman CA, Kallenberg CG, Hoffman GS, Tervaert JW. Patients' perceptions of the effects of systemic lupus erythematosus on health, function, income, and interpersonal relationships: a comparison with Wegener's granulomatosis. Arthritis Rheum 2002; 47: 196201.
  • 2
    Partridge AJ, Karlson EW, Daltroy LH, Lew RA, Wright EA, Fossel AH, et al. Risk factors for early work disability in systemic lupus erythematosus: results from a multicenter study. Arthritis Rheum 1997; 40: 2199206.
  • 3
    Karlson EW, Daltroy LH, Lew RA, Wright EA, Partridge AJ, Roberts WN, et al. The independence and stability of socioeconomic predictors of morbidity in systemic lupus erythematosus. Arthritis Rheum 1995; 38: 26773.
  • 4
    Yelin E, Trupin L, Katz P, Criswell L, Yazdany J, Gillis J, et al. Work dynamics among persons with systemic lupus erythematosus. Arthritis Rheum 2007; 57: 5663.
  • 5
    Jonsen A, Bengtsson AA, Nived O, Ryberg B, Sturfelt G. Outcome of neuropsychiatric SLE within a defined Swedish population: increased morbidity but low mortality. Rheumatology 2002; 41: 130812.
  • 6
    Curry S, Levine S, Corty E, Jones P, Kurit D. The impact of systemic lupus erythematosus on women's sexual functioning. J Rheumatol 1994; 21: 225460.
  • 7
    Liang MH, Rogers M, Larson M, Eaton HM, Murawski BJ, Taylor JE, et al. The psychosocial impact of systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 1984; 27: 139.
  • 8
    Sharpe L, Denton F, Schrieber L. Validity of the disease repercussion profile in patients with systemic lupus erythematosus. Lupus 2004; 13: 42835.
  • 9
    Abu-Shakra M, Mader R, Langevitz P, Friger M, Codish S, Neumann L, et al. Quality of life in systemic lupus erythematosus: a controlled study. J Rheumatol 1999; 26: 3069.
  • 10
    Da Costa D, Dobkin P, Fitzcharles M, Fortin P, Beaulieu A, Zummer M, et al. Determinants of health status in fibromyalgia: a comparative study with systemic lupus erythematosus. J Rheumatol 2000; 27: 36572.
  • 11
    Dobkin PL, Da Costa D, Dritsa M, Fortin PR, Senecal JL, Goulet JR, et al. Quality of life in systemic lupus erythematosus patients during more and less active disease states: differential contributors to mental and physical health. Arthritis Rheum 1999; 12: 40110.
  • 12
    Khanna S, Pal H, Pandey R, Handa R. The relationship between disease activity and quality of life in systemic lupus erythematosus. Rheumatology (Oxford) 2004; 43: 153640.
  • 13
    Alarcon GS, Roseman J, Bartolucci AA, Friedman AW, Moulds JM, Goel N, et al, for the LUMINA Study Group. Systemic lupus erythematosus in three ethnic groups. II. Features predictive of disease activity early in its course. Arthritis Rheum 1998; 41: 117380.
  • 14
    Karlson EW, Daltroy LH, Lew RA, Wright EA, Patridge AJ, Fossel AH, et al. The relationship of socioeconomic status, race, and modifiable risk factors to outcomes in patients with systemic lupus erythematosus. Arthritis Rheum 1997; 40: 4756.
  • 15
    Panopolis P, Petri M, Manzi S, Isenberg D, Gordon C, Senecal J, et al. The systemic lupus erythematosus tri-nation study: longitudinal changes in physical and mental well-being. Rheumatology 2005; 44: 7515.
  • 16
    Verbrugge L, Jette A. The disablement process. Soc Sci Med 1994; 38: 114.
  • 17
    Katz PP, Yelin EH, Lubeck D, Buatti M, Wanke LA. Satisfaction with function: what type of function do rheumatoid arthritis patients value most? [abstract]. Arthritis Rheum 2001; 44: S185.
  • 18
    Katz P, Yelin E, Eisner M, Earnest G, Blanc P. Performance of valued life activities reflected asthma-specfiic quality of life more than general physical function. J Clin Epidemiol 2004; 57: 25967.
  • 19
    Katz PP, Yelin EH. The development of depressive symptoms among women with rheumatoid arthritis: the role of function. Arthritis Rheum 1995; 38: 4956.
  • 20
    Katz PP, Yelin EH. Activity loss and the onset of depressive symptoms: do some activities matter more than others? Arthritis Rheum 2001; 44: 1194202.
  • 21
    Nagi S. Disability concepts revisited: implications for prevention. In: PopeA, TarlovA, editors. Disability in America: toward a national agenda for prevention. Washington, DC: National Academy Press; 1991. p. 30926.
  • 22
    Verbrugge L. The iceberg of disability. In: StahlS, editor. The Legacy of longevity: health and health care in later life. Newbury Park (CA): Sage Publications; 1990. p. 5575.
  • 23
    Verbrugge L. Disability. Rheum Dis Clin North Am 1990; 16: 74161.
  • 24
    Verbrugge L, Gruber-Baldini A, Fozard J. Age differences and age changes in activities: Baltimore Longitudinal Study of Aging. J Gerontol Soc Sci 1996; 51B: S3041.
  • 25
    Freemer M, King TJ, Criswell L. Association of smoking with dsDNA autoantibody production in systemic lupus erythematosus. Ann Rheum Dis 2006; 65: 5814.
  • 26
    Thorburn C, Prokunina-Olsson L, Sterba K, Lum R, Seldin M, Alarcon-Riquelme M, et al. Association of PCDC1 genetic variation with risk and clinical manifestations of systemic lupus erythematosus in a multiethnic cohort. Genes Immun 2007; 8: 27987.
  • 27
    Katz P, Morris A, Yelin E. Prevalence and predictors of disability in valued life activities among individuals with rheumatoid arthritis. Ann Rheum Dis 2006; 65: 7639.
  • 28
    Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980; 23: 13745.
  • 29
    Escalante A, Haas RW, del Rincon I. A model of impairment and functional limitation in rheumatoid arthritis. BMC Musculoskelet Disord 2005; 6: 16.
  • 30
    Karlson E, Daltroy L, Rivest C, Ramsey-Goldman R, Wright E, Patrtridge A, et al. Validation of a systemic lupus activity questionnaire (SLAQ) for population studies. Lupus 2003; 12: 2806.
  • 31
    Ware JJ, Snow K, Kosinski M, Gandek B. SF-36 Health Survey: manual and interpretation guide. Boston: The Health Institute, New England Medical Center; 1993.
  • 32
    Stewart A, Ware JJ, Sherbourne C, Wells K. Psychological distrss/well-being and cognitive functioning measures. In: StewartA, WareJJ, editors. Measuring functioning and well-being: the Medical Outcomes Study approach. Durham, North Carolina: Duke University Press; 1992. p. 10242.
  • 33
    Norman G, Sloan J, Wyrwich K. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. J Clin Epi 2003; 41: 58292.
  • 34
    Ware J, Kosinski M, Keller S. SF-12: How to score the SF-12 Physical and Mental Health Summary Scores. Boston: The Health Institute, New England Medical Center; 1995.
  • 35
    Liang M, Fossel A, Larson M. Comparisons of 5 health status instruments for orthopedic evaluation. Med Care 1990; 28: 63242.
  • 36
    Badley EM, Rothman LM, Wang PP. Modeling physical dependence in arthritis: the relative contribution of specific disabilities and environmental factors. Arthritis Care Res 1998; 11: 33545.
  • 37
    Gignac MA, Cott C, Badley EM. Adaptation to chronic illness and disability and its relationship to perceptions of independence and dependence. J Gerontol B Psychol Sci Soc Sci 2000; 55: P36272.
  • 38
    Hewlett S, Smith A, Kirwan J. Values for function in rheumatoid arthritis: patients, professionals, and public. Ann Rheum Dis 2001; 60: 92833.
  • 39
    Verhoeven A, Boers M, van der Linden S. Validity of the MACTAR questionnaire as a functional index in a rheumatoid arthritis clinical trial. J Rheumatol 2000; 27: 28019.
  • 40
    Tugwell P, Bombardier C, Buchanan W, Goldsmith C, Grace E, Hanna B. The MACTAR Patient Preference Disability Questionnaire: an individualized functional priority approach for assessing improvement in physical disability in clinical trials in rheumatoid arthritis. J Rheumatol 1987; 14: 44651.
  • 41
    Katz PP, Yelin EH. Life activities of persons with rheumatoid arthritis with and without depressive symptoms. Arthritis Care Res 1994; 7: 6977.
  • 42
    Katz P, Eisner M, Yelin E, Trupin L, Earnest G, Balmes J, et al. Functioning and psychological status among individuals with COPD. Qual Life Res 2005; 14: 183543.